Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Osteogenesis Imperfecta
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
29 patients showed mutations in COL1A1 or COL1A2 and were classified as OI.
|
29946973 |
2018 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is characterised by brittle bones and caused by mutations in the type I collagen genes, COL1A1 and COL1A2.
|
11826020 |
2002 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a bone dysplasia caused by mutations in the COL1A1 and COL1A2 genes.
|
18670065 |
2008 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a heritable bone fragility disorder that in the majority of cases is caused by mutations in COL1A1 or COL1A2, the genes that encode the two collagen type I alpha chains, alpha1(I) and alpha2(I).
|
19929435 |
2010 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is most often caused by mutations in the type I procollagen genes (COL1A1/COL1A2).
|
21344539 |
2011 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis Imperfecta (OI) is a heritable connective tissue disorder mainly caused by mutations in the genes COL1A1 and COL1A2 and is associated with hearing loss in approximately half of the cases.
|
22206639 |
2011 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta murine (Oim) mice, with a mutation in Col1a2, have distal leaflet thickening and increased proteoglycan composition characteristic of myxomatous valve disease.
|
22248532 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is an inherited connective tissue disorder with skeletal dysplasia of varying severity, predominantly caused by mutations in the collagen I genes (COL1A1/COL1A2).
|
22589248 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI), or brittle bone disease, is most often caused by dominant mutations in the collagen I genes COL1A1/COL1A2, whereas rarer recessive OI is often caused by mutations in genes encoding collagen I-interacting proteins.
|
24419319 |
2014 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a heterogeneous group of disorders of connective tissue, mainly caused by mutations in the collagen type I genes (COL1A1 and COL1A2).
|
27510842 |
2017 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta is caused by dominant autosomal mutations in the type I collagen coding genes (COL1A1 and COL1A2) in about 85% of individuals, affecting collagen quantity or structure.
|
28820180 |
2017 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta with ectopic mineralizations in dentin and cementum and a COL1A2 mutation.
|
29636545 |
2018 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a heritable connective tissue disorder primarily due to mutations in the type I collagen genes (COL1A1 and COL1A2), leading to compromised biomechanical integrity in type I collagen-containing tissues such as bone.
|
29813187 |
2018 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes.
|
30886339 |
2019 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a heritable connective tissue disorder that most often arises from type I collagen-COL1A1 and COL1A2-gene defects leading to skeletal fragility, short stature, blue-gray sclera, and muscle weakness.
|
30908713 |
2019 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is a group of heritable fragile bone diseases, and the majority are caused by pathogenic variants in the COL1A1 and COL1A2 genes.
|
30913006 |
2019 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) underlies germline mutations in either Col1A1 or Col1A2.
|
9385363 |
1997 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Type I procollagen was purified from the medium of dermal fibroblasts cultured from four individuals with osteogenesis imperfecta (OI) type II who had mutations in the COL1A1 gene of type I procollagen.
|
1460046 |
1992 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Type I procollagen was purified from cultured fibroblasts of a proband with a lethal variant of osteogenesis imperfecta.
|
2036375 |
1991 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
|
3402997 |
1988 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
|
8800927 |
1996 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
A baby with the lethal perinatal form of osteogenesis imperfecta was shown to have a structural defect in the alpha 1(I) chain of type I procollagen.
|
3108247 |
1987 |